A carregar...

Health and Economic Impact of Switching from a 4-Valent to a 9-Valent HPV Vaccination Program in the United States

BACKGROUND: Randomized clinical trials have shown the 9-valent human papillomavirus (HPV) vaccine to be highly effective against types 31/33/45/52/58 compared with the 4-valent. Evidence on the added health and economic benefit of the 9-valent is required for policy decisions. We compare population-...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Natl Cancer Inst
Main Authors: Brisson, Marc, Laprise, Jean-François, Chesson, Harrell W., Drolet, Mélanie, Malagón, Talía, Boily, Marie-Claude, Markowitz, Lauri E.
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6745694/
https://ncbi.nlm.nih.gov/pubmed/26438574
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djv282
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!